View in EDS HTML Full Text PDF Full Text

Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.

Saved in:
Bibliographic Details
Title: Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
Authors: Hilberink JR; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., van Zeventer IA; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Chitu DA; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Pabst T; Department of Oncology, University Hospital, Inselspital, and University of Bern, Bern, Switzerland., Klein SK; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.; Department of Internal Medicine, Meander Hospital Amersfoort, Amersfoort, the Netherlands., Stussi G; Department of Hematology, Oncology Institute of Southern Switzerland, Ospedale Regionale, Bellinzona, Switzerland., Griskevicius L; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania., Valk PJM; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Cloos J; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Breems D; Department of Hematology, ZNA Stuivenberg/Middelheim, Antwerp, Belgium., van Lammeren-Venema D; Department of Hematology, Hagaziekenhuis, Den Haag, the Netherlands., Boersma R; Department of Hematology, Amphia Hospital, Breda, the Netherlands., Jongen-Lavrencic M; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Fehr M; Department of Medical oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland., Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Manz MG; Department of Medical Oncology and Hematology, Universitätsspital Zurich, Zurich, Switzerland., Söhne M; Department of Hematology, Antonius Hospital, Nieuwegein, the Netherlands., van Marwijk Kooy R; Department of Hematology, Isala Hospital, Zwolle, the Netherlands., Deeren D; Department of Hematology, AZ Delta Roeselare, Roeselare, Belgium., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Legdeur MC; Department of Hematology, Medical Spectrum Twente, Enschede, the Netherlands., Tick L; Department of hematology, Maxima Medical Center, Veldhoven, the Netherlands., Chalandon Y; Division of hematology, University Hospital Genève and Faculty of Medicine, University of Genève, Genève, Switzerland., Ammatuna E; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Blum S; Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Löwenberg B; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Huls G; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands. g.huls@umcg.nl.
Corporate Authors: Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), Swiss Group for Clinical Cancer Research (SAKK)
Source: Blood cancer journal [Blood Cancer J] 2023 Jun 19; Vol. 13 (1), pp. 93. Date of Electronic Publication: 2023 Jun 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37336890
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hilberink+JR%22">Hilberink JR</searchLink>; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Zeventer+IA%22">van Zeventer IA</searchLink>; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Chitu+DA%22">Chitu DA</searchLink>; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Pabst+T%22">Pabst T</searchLink>; Department of Oncology, University Hospital, Inselspital, and University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Klein+SK%22">Klein SK</searchLink>; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.; Department of Internal Medicine, Meander Hospital Amersfoort, Amersfoort, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Stussi+G%22">Stussi G</searchLink>; Department of Hematology, Oncology Institute of Southern Switzerland, Ospedale Regionale, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Griskevicius+L%22">Griskevicius L</searchLink>; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania.<br /><searchLink fieldCode="AU" term="%22Valk+PJM%22">Valk PJM</searchLink>; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Cloos+J%22">Cloos J</searchLink>; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+de+Loosdrecht+AA%22">van de Loosdrecht AA</searchLink>; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Breems+D%22">Breems D</searchLink>; Department of Hematology, ZNA Stuivenberg/Middelheim, Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22van+Lammeren-Venema+D%22">van Lammeren-Venema D</searchLink>; Department of Hematology, Hagaziekenhuis, Den Haag, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Boersma+R%22">Boersma R</searchLink>; Department of Hematology, Amphia Hospital, Breda, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Jongen-Lavrencic+M%22">Jongen-Lavrencic M</searchLink>; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Fehr+M%22">Fehr M</searchLink>; Department of Medical oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hoogendoorn+M%22">Hoogendoorn M</searchLink>; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Manz+MG%22">Manz MG</searchLink>; Department of Medical Oncology and Hematology, Universitätsspital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Söhne+M%22">Söhne M</searchLink>; Department of Hematology, Antonius Hospital, Nieuwegein, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Marwijk+Kooy+R%22">van Marwijk Kooy R</searchLink>; Department of Hematology, Isala Hospital, Zwolle, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Deeren+D%22">Deeren D</searchLink>; Department of Hematology, AZ Delta Roeselare, Roeselare, Belgium.<br /><searchLink fieldCode="AU" term="%22van+der+Poel+MWM%22">van der Poel MWM</searchLink>; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Legdeur+MC%22">Legdeur MC</searchLink>; Department of Hematology, Medical Spectrum Twente, Enschede, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Tick+L%22">Tick L</searchLink>; Department of hematology, Maxima Medical Center, Veldhoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Chalandon+Y%22">Chalandon Y</searchLink>; Division of hematology, University Hospital Genève and Faculty of Medicine, University of Genève, Genève, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ammatuna+E%22">Ammatuna E</searchLink>; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Blum+S%22">Blum S</searchLink>; Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Löwenberg+B%22">Löwenberg B</searchLink>; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Ossenkoppele+GJ%22">Ossenkoppele GJ</searchLink>; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Huls+G%22">Huls G</searchLink>; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands. g.huls@umcg.nl.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Dutch-Belgian+Hemato-Oncology+Cooperative+Group+%28HOVON%29%22">Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)</searchLink><br /><searchLink fieldCode="CA" term="%22Swiss+Group+for+Clinical+Cancer+Research+%28SAKK%29%22">Swiss Group for Clinical Cancer Research (SAKK)</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2023 Jun 19; Vol. 13 (1), pp. 93. <i>Date of Electronic Publication: </i>2023 Jun 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37336890
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-023-00850-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 93
    Titles:
      – TitleFull: Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hilberink JR
      – PersonEntity:
          Name:
            NameFull: van Zeventer IA
      – PersonEntity:
          Name:
            NameFull: Chitu DA
      – PersonEntity:
          Name:
            NameFull: Pabst T
      – PersonEntity:
          Name:
            NameFull: Klein SK
      – PersonEntity:
          Name:
            NameFull: Stussi G
      – PersonEntity:
          Name:
            NameFull: Griskevicius L
      – PersonEntity:
          Name:
            NameFull: Valk PJM
      – PersonEntity:
          Name:
            NameFull: Cloos J
      – PersonEntity:
          Name:
            NameFull: van de Loosdrecht AA
      – PersonEntity:
          Name:
            NameFull: Breems D
      – PersonEntity:
          Name:
            NameFull: van Lammeren-Venema D
      – PersonEntity:
          Name:
            NameFull: Boersma R
      – PersonEntity:
          Name:
            NameFull: Jongen-Lavrencic M
      – PersonEntity:
          Name:
            NameFull: Fehr M
      – PersonEntity:
          Name:
            NameFull: Hoogendoorn M
      – PersonEntity:
          Name:
            NameFull: Manz MG
      – PersonEntity:
          Name:
            NameFull: Söhne M
      – PersonEntity:
          Name:
            NameFull: van Marwijk Kooy R
      – PersonEntity:
          Name:
            NameFull: Deeren D
      – PersonEntity:
          Name:
            NameFull: van der Poel MWM
      – PersonEntity:
          Name:
            NameFull: Legdeur MC
      – PersonEntity:
          Name:
            NameFull: Tick L
      – PersonEntity:
          Name:
            NameFull: Chalandon Y
      – PersonEntity:
          Name:
            NameFull: Ammatuna E
      – PersonEntity:
          Name:
            NameFull: Blum S
      – PersonEntity:
          Name:
            NameFull: Löwenberg B
      – PersonEntity:
          Name:
            NameFull: Ossenkoppele GJ
      – PersonEntity:
          Name:
            NameFull: Huls G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 06
              Text: 2023 Jun 19
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1